Ayala Pharmaceuticals, Inc. (AYLA)
NASDAQ: AYLA · IEX Real-Time Price · USD
1.59
-0.02 (-1.24%)
At close: Aug 8, 2022 3:59 PM
1.58
-0.01 (-0.63%)
After-hours:
Aug 8, 2022 7:30 PM EDT
Income Statement (Quarterly)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Quarter Ended | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
|
0.46 | 1.15 | 0.63 | 0.76 | 0.97 | 1 | 0.66 | 1.05 | 1 | 0.37 | 0.85 | 0.85 | 0.27 |
| Revenue Growth (YoY)
|
-52.98% | 14.14% | -5.01% | -27.18% | -2.70% | 169.89% | -22.13% | 22.65% | 277.74% | - | - | - | - |
| Cost of Revenue
|
0.37 | -5.87 | 0.63 | 0.76 | 0.97 | -6.41 | 0.66 | 1.05 | 1 | 0.38 | 0.49 | 0.16 | 0.27 |
| Gross Profit
|
0.09 | 7.01 | 0 | 0 | 0 | 7.42 | 0 | 0 | 0 | -0 | 0.36 | 0.69 | 0 |
| Selling, General & Admin
|
2.44 | 2.24 | 2.2 | 2.54 | 2.3 | 2.65 | 1.86 | 1.55 | 1.31 | 1.52 | 0.95 | 1.02 | 0.85 |
| Research & Development
|
7.5 | 7.53 | 7.37 | 8.12 | 6.93 | 6.79 | 5.42 | 5.07 | 5.13 | 3.86 | 4.37 | 3.44 | 2.75 |
| Operating Expenses
|
9.94 | 9.77 | 9.57 | 10.66 | 9.23 | 9.44 | 7.28 | 6.61 | 6.44 | 5.38 | 5.32 | 4.46 | 3.6 |
| Operating Income
|
-9.85 | -2.76 | -9.57 | -10.66 | -9.23 | -2.03 | -7.28 | -6.61 | -6.44 | -5.39 | -4.96 | -3.77 | -3.6 |
| Interest Expense / Income
|
0 | 0.26 | 0 | 0 | 0 | -0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expense / Income
|
-0.02 | 6.84 | 0.06 | 0.02 | 0.09 | 7.38 | 0.04 | -0.04 | 0.04 | -0.04 | 0.05 | -0.1 | -0.14 |
| Pretax Income
|
-9.84 | -9.85 | -9.63 | -10.68 | -9.32 | -9.35 | -7.32 | -6.57 | -6.48 | -5.34 | -5.01 | -3.67 | -3.46 |
| Income Tax
|
0.19 | 0.2 | 0.17 | 0.16 | 0.25 | 0.05 | 0.12 | 0.14 | 0.12 | 0.08 | 0.04 | 0.11 | 0.08 |
| Net Income
|
-10.03 | -10.05 | -9.8 | -10.84 | -9.57 | -9.4 | -7.44 | -6.71 | -6.6 | -5.42 | -5.05 | -3.78 | -3.54 |
| Net Income Common
|
-10.03 | -10.05 | -9.8 | -10.84 | -9.57 | -9.4 | -7.44 | -6.71 | -6.6 | -5.42 | -5.05 | -3.78 | -3.54 |
| Shares Outstanding (Basic)
|
15 | 15 | 14 | 14 | 13 | 10 | 13 | 9 | 5 | 5 | 5 | 5 | 5 |
| Shares Outstanding (Diluted)
|
15 | 15 | 14 | 14 | 13 | 10 | 13 | 9 | 5 | 5 | 5 | 5 | 5 |
| Shares Change
|
18.72% | 54.17% | 14.36% | 59.86% | 157.79% | 97.43% | 154.57% | 81.28% | 0.78% | - | - | - | - |
| EPS (Basic)
|
-0.66 | -0.66 | -0.68 | -0.75 | -0.74 | -0.73 | -0.59 | -0.74 | -1.32 | -1.08 | -1.01 | -0.76 | -0.71 |
| EPS (Diluted)
|
-0.66 | -0.66 | -0.68 | -0.75 | -0.74 | -0.73 | -0.59 | -0.74 | -1.32 | -1.08 | -1.01 | -0.76 | -0.71 |
| Free Cash Flow Per Share
|
-0.65 | -0.51 | -0.65 | -0.80 | -0.75 | -0.70 | -0.70 | -0.59 | -1.28 | -0.85 | -1.04 | -0.63 | -0.76 |
| Gross Margin
|
19.65% | 611.87% | - | - | - | 738.64% | - | - | - | -0.81% | 42.60% | 81.22% | - |
| Operating Margin
|
-2151.53% | -240.40% | -1530.56% | -1400.39% | -947.43% | -201.79% | -1106.84% | -632.82% | -643.26% | -1447.85% | -586.63% | -442.25% | -1358.49% |
| Profit Margin
|
-2189.30% | -876.88% | -1567.36% | -1424.57% | -982.34% | -936.06% | -1130.39% | -642.30% | -659.14% | -1457.80% | -597.28% | -444.01% | -1335.47% |
| Free Cash Flow Margin
|
-2179.91% | -679.93% | -1499.04% | -1517.87% | -990.66% | -691.63% | -1353.04% | -509.86% | -640.46% | -1135.75% | -609.70% | -367.96% | -1421.89% |
| Effective Tax Rate
|
-1.92% | -2.02% | -1.73% | -1.52% | -2.66% | -0.53% | -1.57% | -2.11% | -1.87% | -1.48% | -0.78% | -3.08% | -2.17% |
| EBITDA
|
-9.81 | -9.56 | -9.58 | -10.75 | -9.16 | -9.36 | -7.27 | -6.54 | -6.42 | -5.24 | -4.99 | -3.66 | -3.44 |
| EBITDA Margin
|
-2141.49% | -834.38% | -1533.28% | -1412.48% | -940.04% | -932.27% | -1105.47% | -625.55% | -641.76% | -1408.87% | -590.41% | -429.81% | -1299.62% |
| Depreciation & Amortization
|
0.03 | 0.03 | 0.05 | -0.07 | 0.16 | 0.04 | 0.05 | 0.04 | 0.05 | 0.1 | 0.02 | 0.01 | 0.02 |
| EBIT
|
-9.84 | -9.59 | -9.63 | -10.68 | -9.32 | -9.4 | -7.32 | -6.57 | -6.48 | -5.34 | -5.01 | -3.67 | -3.46 |
| EBIT Margin
|
-2148.04% | -836.82% | -1540.64% | -1403.29% | -956.88% | -936.65% | -1112.92% | -629.00% | -647.05% | -1436.56% | -592.66% | -430.75% | -1307.17% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).